- CEO
- Arif Esmail Merchant
- Sector
- Distribution services
- Industry
- Wholesale distributors
- Address
- Mumbai India
- IPO Date
- Jan 3, 2025
- Business
- Citichem India Limited is an India-based distributor, trader, importer, and manufacturer of organic, inorganic, specialty, and food-grade chemicals. Founded in 1992 as Citichem Alkalies (Bombay) Private Limited and renamed Citichem India Limited in 1999, the company is headquartered in Mumbai, Maharashtra, India. It operates through an integrated procurement and distribution network, supplying raw materials and chemical intermediates to a diverse base of commercial and industrial clients.
The company offers a comprehensive portfolio across several key product categories, including industrial and basic chemicals such as caustic soda flakes and lye, soda ash light, caustic potash flakes and lye, acetic acid, hydrochloric acid, liquid chlorine, and sulfuric acid; specialty and inorganic chemicals comprising methylene chloride, hydrogen peroxide, potassium carbonate, oxalic acid, bleaching powder, sodium bicarbonate, phthalic anhydride, maleic anhydride, aluminum chloride anhydrous, phenol, acetone, chloroform, and thiourea; food-grade ingredients and additives consisting of monosodium glutamate, citric acid monohydrate, ascorbic acid, food-grade phosphoric acid, and chemical preservatives; and secondary industrial materials including refined glycerin, paraffin wax, recycled plastic materials, pyrolysis oil, PVC resin suspension, carbon black, and technical-grade urea. The company also supplies bulk drugs and pharmaceutical intermediates.
Citichem India serves a wide range of end-user industries throughout India, including pharmaceuticals, agrochemicals, textiles, paints and coatings, soap and detergent manufacturing, paper production, food and beverage processing, aluminum, and steel manufacturing.
In January 2025, Citichem India completed its Initial Public Offering on the BSE SME platform, raising approximately INR 12.60 crore through a fresh equity issuance. The company allocated the net proceeds toward strategic capital expenditures, including property acquisition and the purchase of commercial transport vehicles to expand its internal supply chain and logistics capabilities. Following its public listing, the company has focused on scaling its distribution infrastructure, broadening its domestic sourcing channels, and strengthening its position across specialized industrial and pharmaceutical chemical markets.